ProShares UltraShort Nasdaq Biotechnology (BIS)
BIS is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (-200%). BIS launched on Apr 7, 2010 and has a 0.95% expense ratio.
ETF Info
US74347B7890
74347G838
Apr 7, 2010
North America (U.S.)
2x
NASDAQ Biotechnology Index (-200%)
Multi-Cap
Growth
Expense Ratio
BIS has a high expense ratio of 0.95%, indicating above-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
ProShares UltraShort Nasdaq Biotechnology (BIS) returned 10.74% year-to-date (YTD) and 15.86% over the past 12 months. Over the past 10 years, BIS returned -16.10% annually, underperforming the S&P 500 benchmark at 10.77%.
BIS
10.74%
-6.50%
33.69%
15.86%
-10.59%
-16.10%
^GSPC (Benchmark)
0.08%
9.75%
-1.63%
12.74%
15.66%
10.77%
Monthly Returns
The table below presents the monthly returns of BIS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -8.96% | 0.36% | 13.02% | -3.81% | 11.49% | 10.74% | |||||||
| 2024 | -0.45% | -1.80% | 0.40% | 13.54% | -10.12% | -6.26% | -11.77% | -1.43% | 4.92% | 6.11% | -0.81% | 16.22% | 4.79% |
| 2023 | -6.87% | 13.75% | -2.47% | -2.81% | 5.73% | 0.06% | -2.07% | 1.32% | 8.97% | 14.73% | -9.45% | -21.67% | -6.54% |
| 2022 | 25.57% | 7.14% | -10.70% | 20.24% | -1.72% | -5.41% | -8.68% | 0.16% | 2.52% | -17.13% | -11.41% | 5.88% | -2.14% |
| 2021 | -12.50% | 3.75% | 5.47% | -6.60% | 2.84% | -15.06% | -0.60% | -9.57% | 9.13% | 3.33% | 7.24% | 0.40% | -14.74% |
| 2020 | 12.01% | -2.33% | -3.66% | -27.80% | -16.70% | -5.19% | 1.62% | -2.94% | -2.35% | 5.67% | -20.59% | -9.43% | -56.01% |
| 2019 | -23.59% | -5.78% | 0.76% | 9.71% | 12.18% | -16.59% | 5.99% | 4.49% | 6.55% | -14.24% | -20.15% | -1.95% | -41.01% |
| 2018 | -13.42% | 9.48% | 1.15% | 4.64% | -9.27% | -2.99% | -11.76% | -9.20% | 0.30% | 33.27% | -10.13% | 23.71% | 5.14% |
| 2017 | -10.20% | -12.73% | 1.42% | -3.06% | 7.49% | -16.29% | -6.02% | -9.47% | -0.29% | 12.20% | -1.39% | -3.16% | -36.98% |
| 2016 | 53.67% | 7.16% | -7.87% | -7.92% | -10.12% | 15.42% | -22.35% | 5.01% | -6.81% | 24.89% | -16.03% | 5.52% | 21.87% |
| 2015 | -12.24% | -9.86% | -5.19% | 4.09% | -17.21% | -3.40% | -8.50% | 20.78% | 21.46% | -16.42% | -6.70% | -4.49% | -37.59% |
| 2014 | -16.38% | -15.18% | 21.72% | 1.63% | -9.28% | -13.33% | 2.88% | -18.29% | 0.58% | -16.94% | -5.76% | -2.38% | -55.43% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BIS is 36, indicating average performance compared to other ETFs on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
ProShares UltraShort Nasdaq Biotechnology provided a 3.26% dividend yield over the last twelve months, with an annual payout of $0.65 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend | $0.65 | $0.68 | $0.32 | $0.00 | $0.00 | $0.10 | $1.13 | $0.34 |
Dividend yield | 3.26% | 3.73% | 1.75% | 0.00% | 0.00% | 0.44% | 2.10% | 0.37% |
Monthly Dividends
The table displays the monthly dividend distributions for ProShares UltraShort Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | |||||||
| 2024 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.21 | $0.68 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.18 | $0.32 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.10 |
| 2019 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.16 | $1.13 |
| 2018 | $0.07 | $0.00 | $0.00 | $0.27 | $0.34 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ProShares UltraShort Nasdaq Biotechnology was 99.77%, occurring on Sep 19, 2024. The portfolio has not yet recovered.
The current ProShares UltraShort Nasdaq Biotechnology drawdown is 99.67%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.77% | Jul 7, 2010 | 3482 | Sep 19, 2024 | — | — | — |
| -13.04% | Jun 10, 2010 | 3 | Jun 15, 2010 | 9 | Jul 1, 2010 | 12 |
| -11.83% | May 7, 2010 | 4 | May 12, 2010 | 5 | May 20, 2010 | 9 |
| -9.45% | May 27, 2010 | 4 | Jun 3, 2010 | 2 | Jun 8, 2010 | 6 |
| -6.59% | Apr 28, 2010 | 2 | Apr 29, 2010 | 4 | May 5, 2010 | 6 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...